- Home
- LQDA vs SPHR Comparison
LQDA vs SPHR Comparison
Compare LQDA & SPHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LQDA
- SPHR
- Stock Information
- Founded
- LQDA 2004
- SPHR 2020
- Country
- LQDA United States
- SPHR United States
- Employees
- LQDA N/A
- SPHR N/A
- Industry
- LQDA Biotechnology: Pharmaceutical Preparations
- SPHR Services-Misc. Amusement & Recreation
- Sector
- LQDA Health Care
- SPHR Consumer Discretionary
- Exchange
- LQDA Nasdaq
- SPHR Nasdaq
- Market Cap
- LQDA 1.3B
- SPHR 1.3B
- IPO Year
- LQDA 2018
- SPHR N/A
- Fundamental
- Price
- LQDA $13.17
- SPHR $38.56
- Analyst Decision
- LQDA Strong Buy
- SPHR Buy
- Analyst Count
- LQDA 9
- SPHR 10
- Target Price
- LQDA $27.67
- SPHR $46.70
- AVG Volume (30 Days)
- LQDA 3.0M
- SPHR 527.8K
- Earning Date
- LQDA 08-06-2025
- SPHR 08-13-2025
- Dividend Yield
- LQDA N/A
- SPHR N/A
- EPS Growth
- LQDA N/A
- SPHR N/A
- EPS
- LQDA N/A
- SPHR N/A
- Revenue
- LQDA $14,144,000.00
- SPHR $1,031,650,000.00
- Revenue This Year
- LQDA $185.38
- SPHR $9.19
- Revenue Next Year
- LQDA $350.95
- SPHR $6.40
- P/E Ratio
- LQDA N/A
- SPHR N/A
- Revenue Growth
- LQDA N/A
- SPHR 16.89
- 52 Week Low
- LQDA $8.26
- SPHR $23.89
- 52 Week High
- LQDA $19.41
- SPHR $50.88
- Technical
- Relative Strength Index (RSI)
- LQDA 36.80
- SPHR 57.23
- Support Level
- LQDA $13.60
- SPHR $37.94
- Resistance Level
- LQDA $14.63
- SPHR $40.06
- Average True Range (ATR)
- LQDA 0.96
- SPHR 1.18
- MACD
- LQDA -0.40
- SPHR -0.26
- Stochastic Oscillator
- LQDA 0.46
- SPHR 50.56
About LQDA Liquidia Corporation
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.
About SPHR Sphere Entertainment Co.
Sphere Entertainment Co is a live entertainment and media company. The firm creates, writes, casts, produces, and tours shows and events. The group has two reportable segments which includeSphere and MSG Networks. Sphere is a next-generation entertainment medium, and MSG Networks operates two regional sports and entertainment networks, as well as a direct-to-consumer (DTC) and authenticated streaming product.